3-nitropropionic acid has been researched along with Alzheimer Disease in 6 studies
3-nitropropionic acid: succinate dehydrogenase inactivator; biosynthesized by FABACEAE plants from ASPARAGINE
3-nitropropanoic acid : A C-nitro compound that is propanoic acid in which one of the methyl hydrogens has been replaced by a nitro group.
Alzheimer Disease: A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| O'Connor, T | 1 |
| Sadleir, KR | 1 |
| Maus, E | 1 |
| Velliquette, RA | 1 |
| Zhao, J | 1 |
| Cole, SL | 1 |
| Eimer, WA | 1 |
| Hitt, B | 1 |
| Bembinster, LA | 1 |
| Lammich, S | 1 |
| Lichtenthaler, SF | 1 |
| Hébert, SS | 1 |
| De Strooper, B | 1 |
| Haass, C | 1 |
| Bennett, DA | 1 |
| Vassar, R | 1 |
| Niatsetskaya, Z | 1 |
| Basso, M | 1 |
| Speer, RE | 1 |
| McConoughey, SJ | 1 |
| Coppola, G | 1 |
| Ma, TC | 1 |
| Ratan, RR | 1 |
| Büchner, M | 2 |
| Huber, R | 2 |
| Sturchler-Pierrat, C | 1 |
| Staufenbiel, M | 1 |
| Riepe, MW | 3 |
| von Arnim, CA | 2 |
| Hellweg, R | 1 |
| Verstege, E | 1 |
| Etrich, SM | 1 |
| Arias, C | 1 |
| Montiel, T | 1 |
| Quiroz-Báez, R | 1 |
| Massieu, L | 1 |
6 other studies available for 3-nitropropionic acid and Alzheimer Disease
| Article | Year |
|---|---|
Phosphorylation of the translation initiation factor eIF2alpha increases BACE1 levels and promotes amyloidogenesis.
Topics: Age Factors; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precu | 2008 |
HIF prolyl hydroxylase inhibitors prevent neuronal death induced by mitochondrial toxins: therapeutic implications for Huntington's disease and Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Cell Death; Enzyme Inhibitors; Huntington Disease; Hypoxia-Inducible Fac | 2010 |
Impaired hypoxic tolerance and altered protein binding of NADH in presymptomatic APP23 transgenic mice.
Topics: Action Potentials; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Disease Models, Anima | 2002 |
Regional selectivity of amyloid mRNA expression and neurotrophins on repetitive inhibition of oxidative phosphorylation.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Brain; Brain Chemistry; Brain-Derived Ne | 2005 |
Mechanisms of hypoxic tolerance in presymptomatic APP23 transgenic mice.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Disease Models, Animal; Gene Expression | 2006 |
beta-Amyloid neurotoxicity is exacerbated during glycolysis inhibition and mitochondrial impairment in the rat hippocampus in vivo and in isolated nerve terminals: implications for Alzheimer's disease.
Topics: Adenosine Triphosphate; Alzheimer Disease; Amyloid beta-Peptides; Animals; Disease Models, Animal; D | 2002 |